The Irish Medicines Board has recalled all stocks of the anti-depressant Seroxat at wholesale level.
This follows revelations on RTE Radio's Liveline programme that GlaxoSmithKline had changed the patient information leaflet in Britain without changing it in Ireland.
Some users had experienced difficulties coming off the popular prescribed drug.
